MBX MBX Biosciences, Inc.
Biotechnology NasdaqGS
Trading Signals (MBX)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $8.04
- Medium Support $9.78
- Weak Support $11.51
Resistance Levels
- Weak Resistance $14.99
- Medium Resistance $16.72
- Strong Resistance $18.46
Stop Loss Suggestions
- Conservative $11.86
- Moderate $10.64
- Aggressive $8.91
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (MBX)
Quarterly Outlook :
2025-12-13
Bullish Scenario
from current 44.91%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
2025-12-13
Base Scenario
from current 10.78%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
2025-12-13
Bearish Scenario
from current -35.92%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
Annual Outlook
2025-12-13
Bullish Scenario
from current 89.81%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
2025-12-13
Base Scenario
from current 21.55%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
2025-12-13
Bearish Scenario
from current -71.85%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (18.03) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (50.63) is in bullish territory, indicating upward momentum. MACD line (0.12) is above Signal line (-0.57) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 2.38, indicating the average weekly price range.
Technical Analysis (MBX)
Trend Identification
EMA
Exponential Moving Average
Current price (13.25) is above both Short MA (13.21) and Long MA (12.04). This indicates strong bullish momentum. Short MA (13.21) is above Long MA (12.04), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. All MAs are in bullish order (Price > Short MA > Long MA > Very Long MA 10.52). This is a strong bullish alignment. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.1300) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). This is a strong buy signal. Consider long positions.
ADX
Average Directional Index
ADX (26.11) indicates a strong trend is present. +DI (22.77) is above -DI (15.89), suggesting a bullish directional bias. This combination points to a strong upward trend. Consider taking long positions, as the strong upward trend is confirmed.
Momentum Measurement
RSI (2025-12-13)
Relative Strength Index
RSI (51.66) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2025-12-13)
On-Balance Volume
OBV (6037037.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-12-13)
Stochastic Oscillator
Stochastics (%K: 63.66, %D: 70.90) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed, potentially signaling a downward trend reversal or continuation. Stronger signal if this occurs above 50.
CCI (2025-12-13)
Commodity Channel Index
CCI (47.16) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2025-12-13)
Average True Range
Current ATR is 1.5000. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-12-13)
Volatility Bands
Current price (13.25) is within the Bollinger Bands (11.16 - 15.26). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (13.21), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals (MBX)
SAR (2025-12-13)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 11.94 is 9.89% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-12-13)
Neutral
Stochastic is in neutral territory (63.7). No clear overbought/oversold signal. Current crossover status: Bearish.
RSI (2025-12-13)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-12-13)
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (MBX)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | INSTITUTIONAL | 5985347 | 17.91% | 2025-03-31 |
| Orbimed Advisors LLC. | INSTITUTIONAL | 4002887 | 11.98% | 2025-03-31 |
| NEA Management Company, LLC | INSTITUTIONAL | 3614486 | 10.81% | 2025-03-31 |
| Deep Track Capital, Lp | INSTITUTIONAL | 3018935 | 9.03% | 2025-03-31 |
| Wellington Management Group, LLP | INSTITUTIONAL | 2638521 | 7.89% | 2025-03-31 |
| NVP Associates, LLC | INSTITUTIONAL | 2136335 | 6.39% | 2025-03-31 |
| Driehaus Capital Management, LLC | INSTITUTIONAL | 1579207 | 4.72% | 2025-03-31 |
| RA Capital Management, L.P. | INSTITUTIONAL | 1511334 | 4.52% | 2025-03-31 |
| EcoR1 Capital, LLC | INSTITUTIONAL | 1259273 | 3.77% | 2025-03-31 |
| MPM BIOIMPACT LLC | INSTITUTIONAL | 1132950 | 3.39% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 400645 | 1.2% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 267785 | 0.8% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 175611 | 0.53% | 2025-03-31 |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | MUTUALFUND | 136900 | 0.41% | 2025-01-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | MUTUALFUND | 113635 | 0.34% | 2025-02-28 |
| Driehaus Mutual Funds-Driehaus Micro Cap Growth Fund | MUTUALFUND | 110703 | 0.33% | 2025-03-31 |
| NORTHWESTERN MUTUAL SERIES FUND INC-Small Cap Growth Stock Portfolio | MUTUALFUND | 77052 | 0.23% | 2025-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | MUTUALFUND | 59482 | 0.18% | 2025-04-30 |
| HARTFORD SERIES FUND INC-HARTFORD SMALL CAP GROWTH HLS FUND | MUTUALFUND | 58452 | 0.17% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 Growth ETF | MUTUALFUND | 54914 | 0.16% | 2025-04-30 |